🔰Hanzal (Indrayan) in Diabetes: A Potent Unani Drug that Modern Science is beginning to Understand

Citrullus colocynthis — Unani Hanzal, Hindi Indrayan, English Bitter Apple — is not merely another “herbal remedy” for Ziabetus (Diabetes Mellitus).

In Unani therapeutics, Hanzal represents a powerful pharmacological drug whose therapeutic value depends fundamentally on correct selection, processing, dose and clinical supervision.

🔬 What does modern evidence show?

Human clinical studies have reported meaningful reductions in Fasting Blood Glucose and HbA1c with standardized C. colocynthis preparations.

A double-blind clinical trial in Type 2 diabetes reported significant improvement in FBS and HbA1c with 100 mg capsules, three times daily for 2 months, while another randomized trial involving 70 patients demonstrated significant reductions in both FBS and HbA1c over 2 months.

Experimental research further supports its potential hypoglycaemic, antioxidant and metabolic actions, providing a scientific basis for continued investigation.

Interestingly, modern literature does not completely reject its antidiabetic potential. Rather, systematic review evidence highlights that existing trials are few and relatively small, calling for larger and better-designed studies.

🌿 THE APPLIED UNANI MESSAGE

The question should not be:

“Does Hanzal work or not?”

The better clinical question is:

❗“In WHICH Ziabetus patient, in WHAT formulation, at WHAT dose, for WHAT duration, and under WHAT monitoring does Hanzal work best?”

This is precisely where Applied Unani Medicine can advance.

Hanzal should be viewed as a potent therapeutic agent—not a casual dietary herb.

Its clinical application demands:

Patient selection → appropriate preparation → dose discipline → glucose monitoring → assessment of renal/hepatic status → periodic therapeutic review.

⚠️ Its potency also explains its toxicity potential. Excessive or inappropriate use can produce severe gastrointestinal effects and systemic toxicity. Therefore, traditional potency must be matched with modern safety monitoring.


FROM TRADITION TO PRECISION

The future is not to abandon Hanzal because modern evidence is still developing.

The future is to standardize Hanzal, identify responsive Ziabetus phenotypes, define therapeutic windows, study mechanisms, and generate high-quality clinical evidence.

🌿 Unani already gave us the therapeutic experience.
Modern science can help us define the therapeutic boundaries.
Applied Unani Medicine must bring both together.

📦 COMMITMENT BOX

🔹 Respect centuries of Unani clinical experience.
🔹 Scientifically validate—not dismiss—traditional drugs.
🔹 Convert empirical success into reproducible protocols.
🔹 Establish dose–response–toxicity boundaries.
🔹 Move from “herbal remedy” → “precision Applied Unani pharmacotherapy.”

Hanzal is not a weak herb.
It is a strong drug that deserves strong science.

#AppliedUnaniMedicine #UnaniMedicine #Hanzal #Indrayan #CitrullusColocynthis #Ziabetus #Diabetes #DiabetesManagement #Phytotherapy #EvidenceBasedUnani #IntegrativeMedicine #UnaniPharmacology

Comments

Popular posts from this blog

🔰Liver-Centric Cholesterol Regulation

🔰Why Does Human Temperament Change Throughout Life? A Unani Perspective on the Four Stages of Sinn

🔰How Genomics Can Help a Unani Physician in Precise Mizaj Evaluation: A New Frontier of Precision Unani Medicine